文献速递关节外科

住院择期全髋与全膝关节置换术后院内死亡趋势:2016至2023年人群研究

Trends of Inhospital Mortality After Inpatient Elective Total Hip and Knee Arthroplasty: A 2016 to 2023 Population-Based Study.
PubMed 文献 · J Arthroplasty · 2026-06-29

基于美国数据库的回顾性分析纳入2016至2023年接受住院择期全髋或全膝关节置换的成人患者,描述院内死亡趋势。全髋置换549,236例的死亡率从0.04%升至0.13%,全膝置换840,991例从0.03%升至0.05%,死亡事件从高手术量医院转向低手术量医院,且死亡相关住院的经通胀调整费用上升。

要点

  • 住院择期全髋置换院内死亡率由0.04%升至0.13%,全膝置换由0.03%升至0.05%。
  • 死亡患者特征保持稳定,呼吸衰竭、急性肾损伤、心律失常与电解质紊乱为最常见并发症。
  • 死亡事件在高手术量医院占比下降,同时死亡相关住院费用上升。

核心结论

  • 住院择期全髋与全膝置换术后院内死亡率仍很低,但2016至2023年两者均呈上升趋势。
  • 死亡率从高手术量医院向低手术量医院转移,合并费用上升,可能提示中心间经验、方案与资源差异扩大。

研究设计与样本

  • 回顾性分析,使用美国数据库,时间范围2016至2023年。
  • 纳入接受住院择期全髋置换与全膝置换的成人患者,全髋549,236例、全膝840,991例。

主要发现

  • 全髋置换院内死亡率2016至2017年为0.04%,2022至2023年为0.13%(P < 0.001)。
  • 全膝置换院内死亡率2016至2017年为0.03%,2022至2023年为0.05%(P = 0.006)。
  • 死亡患者的人口学与临床特征保持稳定。
  • 死亡相关住院的经通胀调整费用上升:全髋2016至2017年33.1千美元(19.3至52.2)对比2022至2023年42.2千美元(31.1至56.5),P = 0.026;全膝29.6千美元(19.4至46.5)对比33.1千美元(20.9至57.8),P < 0.001。
  • 死亡事件在高手术量医院占比下降:全髋21.7%降至7.0%(P = 0.0015),全膝27.0%降至6.9%(P < 0.01)。

关键数值与推荐

  • 死亡病例中最常见的并发症为呼吸衰竭、急性肾损伤、心律失常与电解质紊乱,并发症谱保持稳定。

临床怎么用

  • 应关注住院择期髋膝关节置换术后院内死亡率的上升趋势,尤其在低手术量医院加强围手术期管理与资源配置。
  • 对高龄、合并症较多的患者应强化风险评估与并发症防治,重点关注呼吸衰竭、急性肾损伤、心律失常与电解质紊乱。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Utilization of inpatient total hip arthroplasty and total knee arthroplasty (THA and TKA) has surged in older, more comorbid patients, but the impact of this shift on inhospital mortality remains unclear. Using a United States database, we described inhospital mortality trends of inpatient THA and TKA. METHODS: This retrospective analysis (2016 to 2023) included adults undergoing inpatient elective THA and TKA. We described inhospital mortality rate trends. We then focused only on patients who experienced inhospital mortality and described patient, health care, hospital, and complication profile trends. RESULTS: Mortality rates tripled for 549,236 inpatient THAs (2016 to 2017: 0.04% versus 2022 to 2023: 0.13%, P < 0.001) and increased for 840,991 inpatient TKAs (2016 to 2017: 0.03% versus 2022 to 2023: 0.05%, P = 0.006). Patient characteristics among those who died were stable. For both procedures, the inflation-adjusted cost of mortality-associated hospitalizations increased (thousands of United States Dollars; THA, 2016 to 2017: 33.1 [19.3 to 52.2] versus 2022 to 2023: 42.2 [31.1 to 56.5]; P = 0.026 and TKA, 2016 to 2017: 29.6 [19.4 to 46.5] versus 2022 to 2023: 33.1 [20.9 to 57.8]; P < 0.001). The proportion of mortality events decreased in high-case volume hospitals (THA, 2016 to 2017: 21.7% versus 2022 to 2023: 7.0%; P = 0.0015 and TKA, 2016 to 2017: 27.0% versus 2022 to 2023: 6.9%; P < 0.01). Complication profiles remained consistent, with respiratory failure, acute kidney injury, arrhythmia, and electrolyte disorders being the most common. CONCLUSIONS: Although mortality after inpatient THA and TKA remains very low, we observed increasing trends for both procedures. These trends may reflect greater utilization in older, more comorbid patients, alongside the transition of younger, healthier patients to outpatient settings. Importantly, mortality shifted from high-volume to low-volume hospitals; combined with rising costs, this may signal widening disparities in experience, protocols, and resources between centers.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Giannakis P, Rowe JE, Ren R, et al. Trends of Inhospital Mortality After Inpatient Elective Total Hip and Knee Arthroplasty: A 2016 to 2023 Population-Based Study. J Arthroplasty. 2026. PMID: 42373019. doi:10.1016/j.arth.2026.06.068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。